Citation:Munhoz RR, Pereira AA, Sasse AD, Hoff PM, Traina TA, Hudis CA, et al 2016
From Cancer Guidelines Wiki
Citation
Munhoz RR, Pereira AA, Sasse AD, Hoff PM, Traina TA, Hudis CA, et al. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis. JAMA Oncol 2016 Jan;2(1):65-73 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26426573.
Critical appraisals
Compare quality appraisals for each clinical question
- [[Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?|Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?</span></span></span></span>»]] (compare critical appraisals)